ProShare Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-684
| Closed | -$40K | – | 2379 |
|
|
2021
Q1 | $40K | Buy |
684
+117
| +21% | +$6.84K | ﹤0.01% | 2236 |
|
|
2020
Q4 | $21K | Sell |
567
-177
| -24% | -$6.56K | ﹤0.01% | 2087 |
|
|
2020
Q3 | $40K | Buy |
744
+58
| +8% | +$3.12K | ﹤0.01% | 1606 |
|
|
2020
Q2 | $173K | Buy |
686
+263
| +62% | +$66.3K | ﹤0.01% | 1494 |
|
|
2020
Q1 | $67K | Sell |
423
-311
| -42% | -$49.3K | ﹤0.01% | 1105 |
|
|
2019
Q4 | $120K | Sell |
734
-75
| -9% | -$12.3K | ﹤0.01% | 1674 |
|
|
2019
Q3 | $118K | Sell |
809
-12
| -1% | -$1.75K | ﹤0.01% | 1531 |
|
|
2019
Q2 | $171K | Sell |
821
-87
| -10% | -$18.1K | ﹤0.01% | 1469 |
|
|
2019
Q1 | $189K | Buy |
908
+86
| +10% | +$17.9K | ﹤0.01% | 1486 |
|
|
2018
Q4 | $144K | Sell |
822
-159
| -16% | -$27.9K | ﹤0.01% | 1432 |
|
|
2018
Q3 | $222K | Sell |
981
-39
| -4% | -$8.83K | ﹤0.01% | 1537 |
|
|
2018
Q2 | $154K | Sell |
1,020
-46
| -4% | -$6.95K | ﹤0.01% | 1665 |
|
|
2018
Q1 | $195K | Sell |
1,066
-159
| -13% | -$29.1K | ﹤0.01% | 1558 |
|
|
2017
Q4 | $261K | Buy |
+1,225
| New | +$261K | ﹤0.01% | 1487 |
|